Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer

OBJECTIVE: To assess the impact of Guide to Decide (GtD), a web-based, personally-tailored decision aid designed to inform women’s decisions about prophylactic tamoxifen and raloxifene use. METHODS: Postmenopausal women, age 46–74, with BCRAT 5-year risk ≥1.66% and no prior history of breast cancer...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Banegas, Matthew P., McClure, Jennifer B., Barlow, William E., Ubel, Peter A., Smith, Dylan M., Zikmund-Fisher, Brian J., Greene, Sarah M., Fagerlin, Angela
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3650477/
https://ncbi.nlm.nih.gov/pubmed/23395006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pec.2012.12.014
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items